CANADA LIFE ASSURANCE Co - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$110
-2.7%
24,225
+52.2%
0.00%
Q2 2023$113
+121.6%
15,921
+90.9%
0.00%
Q1 2023$51
+4.1%
8,341
+8.7%
0.00%
Q4 2022$49
-99.9%
7,670
+4.6%
0.00%
Q3 2022$70,000
-11.4%
7,335
+2.3%
0.00%
Q2 2022$79,000
-35.8%
7,168
+2.2%
0.00%
Q1 2022$123,000
-5.4%
7,012
+2.4%
0.00%
Q4 2021$130,000
-21.7%
6,851
+2.3%
0.00%
Q3 2021$166,000
-4.6%
6,6980.0%0.00%
Q2 2021$174,000
-17.5%
6,6980.0%0.00%
-100.0%
Q1 2021$211,000
-36.4%
6,698
-6.4%
0.00%0.0%
Q4 2020$332,000
+40.7%
7,1580.0%0.00%0.0%
Q3 2020$236,000
+21.0%
7,1580.0%0.00%
Q2 2020$195,000
-9.7%
7,1580.0%0.00%
-100.0%
Q1 2020$216,000
+10.2%
7,1580.0%0.00%
Q4 2019$196,000
-44.8%
7,158
-50.8%
0.00%
-100.0%
Q2 2019$355,000
+157.2%
14,5380.0%0.00%
Q1 2019$138,000
+11.3%
14,5380.0%0.00%
Q4 2018$124,000
+27.8%
14,538
+67.4%
0.00%
Q3 2018$97,000
-12.6%
8,6850.0%0.00%
Q2 2018$111,000
-24.5%
8,6850.0%0.00%
Q1 2018$147,000
+19.5%
8,685
-44.1%
0.00%
Q4 2017$123,00015,5410.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders